VITASPRING BIOMEDICAL CO., LTD. Increase (Decrease) in Employee Related Liabilities
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Increase (Decrease) in Employee Related Liabilities of $0 for the 3-month period ending 2024-04-30, per its 10-Q filed 2026-04-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-04-02
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for the quarter ending 2024-04-30 was $0.00, a 100.00% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for the quarter ending 2023-04-30 was $33.03K.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for the quarter ending 2021-04-30 was $162.00, a 98.38% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for fiscal 2023 was $35.12K.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in employee related liabilities for fiscal 2021 was $93.03K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2024-04-30 | $0.00 10-Q · filed 2026-04-02 | |||
| 2024-01-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2023-04-30 | $33.03K 10-Q · filed 2026-04-02 | |||
| 2023-01-31 | $35.12K 10-K · filed 2026-03-12 | |||
| 2022-04-30 | $0.00 10-Q · filed 2026-01-13 | |||
| 2022-01-31 | $0.00 10-K · filed 2025-12-01 | |||
| 2021-04-30 | $162.00 10-Q · filed 2021-06-14 | $12.82K derived: sum of 2 quarters · filed 2021-06-14 | $59.94K derived: sum of 3 quarters · filed 2021-06-14 | $83.22K derived: sum of 4 quarters · filed 2021-06-14 |
| 2021-01-31 | $12.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | $59.78K derived: sum of 2 quarters · filed 2021-04-14 | $83.06K derived: sum of 3 quarters · filed 2021-04-14 | $93.03K 10-K · filed 2021-04-14 |
| 2020-10-31 | $47.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-12-15 | $70.40K derived: sum of 2 quarters · filed 2020-12-15 | $80.38K 10-Q · filed 2020-12-15 | $79.58K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-07-31 | $23.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-09-28 | $33.26K 10-Q · filed 2020-09-28 | $32.46K derived: sum of 3 quarters · filed 2021-06-14 | $33.26K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-04-30 | $9.98K 10-Q · filed 2021-06-14 | $9.18K derived: sum of 2 quarters · filed 2021-06-14 | $9.98K derived: sum of 3 quarters · filed 2021-06-14 | |
| 2020-01-31 | -$800.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-14 | $0.00 derived: sum of 2 quarters · filed 2021-04-14 | $0.00 10-K · filed 2021-04-14 | |
| 2019-10-31 | $800.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-12-15 | $800.00 10-Q · filed 2020-12-15 | ||
| 2019-07-31 | $0.00 10-Q · filed 2020-09-28 |